文献库 文献相关信息

题目:
Clinical implications of DLL4 expression in gastric cancer.
作者:
Ishigami(Sumiya),Arigami(Takaaki),Uenosono(Yoshikazu),Okumura(Hiroshi),Kurahara(Hiroshi),Uchikado(Yasuto),Setoyama(Tetsuro),Kita(Yoshiaki),Kijima(Yuko),Nishizono(Yuka),Nakajo(Akihiro),Owaki(Tetsuro),Ueno(Shinichi),Natsugoe(Shoji)
状态:
发布时间2013-08-15 , 更新时间 2015-04-23
期刊:
J Exp Clin Cancer Res
摘要:
Delta-like ligand 4 (DLL4)-Notch signaling plays a key role in tumor neovascular development and angiogenesis during tumor growth. The clinical significance of DLL4 expression in gastric cancer has not been clarified.,Gastric cancer cell lines and 180 gastric cancer patients were enrolled. DLL4 expression in gastric cancer cells and stroma was identified and evaluated immunohistochemically. The association between DLL4 and clinicopathological factors was also assessed.,DLL4 expression was identified in the cellular membrane and cytoplasm of gastric cancer cells by immunoblotting and immunohistochemical staining. DLL4 positivity in cancer cells and stroma was found in 88 (48%) and 41 (22%) of the 180 gastric cancer patients respectively. Both cancer and stromal DLL4 expression significantly correlated with more advanced tumor depth, nodal involvement, and lymphatic and venous invasion. A strongly positive association between cancerous and stromal DLL4 expression was identified (p < 0.01). Both cancerous and stromal DLL4 expression were prognostic markers in gastric cancer as determined by univariate analysis.,Cancerous and stromal DLL4 expression was found in 48% and 22% in gastric cancer, and significantly affected postoperative clinical outcomes. Cancerous and stromal DLL4 expression may be an effective target of anti-DLL4 treatment in gastric cancer.
语言:
eng
DOI:

联系方式

山东省济南市 高新区 崇华路359号 三庆世纪财富中心C1115室

电话: 0531-88819269

E-mail: product@genelibs.com

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。